← FDA Drug Approvals (Drugs@FDA)
NOREPINEPHRINE BITARTRATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2021-05-06
Drug application
- FDA Application #
ANDA214323- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NOREPINEPHRINE BITARTRATE
- Generic name
- NOREPINEPHRINE BITARTRATE
- Active ingredients
- NOREPINEPHRINE BITARTRATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- GLAND
- Manufacturer
- Sagent Pharmaceuticals
- First approval
- 2021-05-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown